TransMedics Group is leveraging its technological and logistical moat in organ transport, with OCS and NOP programs driving ...

TransMedics delivered solid year-over-year growth in Q3, despite seasonal weakness and concerns over U.S. liver market saturation. The next-gen heart and lung trials, along with an increased focus on ...

TransMedics remains the top dog in its industry and may have a widening moat. The founder-led company's shares have risen eightfold since 2019. TransMedics is consistently considered "overvalued," but ...

Both have helped transform their respective industries.

These healthcare growth stocks are profitable and revenue is growing at a double-digit pace. Intuitive Surgical is the top global player in the field of robotic surgery. TransMedics Group is ...

As a cardiac surgery research fellow at the West Roxbury VA Medical Center in the 1990s, Dr. Waleed Hassanein watched as a tragic, fundamental problem unfolded over and over again. Donated organs ...

TransMedics (TMDX) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.19 per share a year ago. These figures ...

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The ...